Sagar Lonial

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Topics

Peritoneal Dialysis

Multiple Myeloma

Epidermal Growth Factor Receptor

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer journal

Blood cancer discovery

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Pinkal M Desai, Sagar Lonial, Amanda F Cashen, Manali Kamdar, Ian W Flinn, Susan M O'Brien, Jacqueline S Garcia, Neha Korde, Javid J Moslehi, Margaret Wey, Patricia Cheung, Shringi Sharma, Damilola Olabode, Hong Chen, Firasath Ali Syed, Mary Liu, Marcio Andrade-Campos, Tapan Mahendra Kadia, James S Blachly
A PHASE 1 FIRST-IN-HUMAN STUDY OF THE MCL-1 INHIBITOR AZD5991 IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Nisha S Joseph, Jonathan L Kaufman, Vilas A Gupta, Craig C Hofmeister, Madhav V Dhodapkar, Lawrence H Boise, Sara M DiCamillo, Danielle Roberts, Ajay K Nooka, Sagar Lonial
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients. Blood cancer journal 14 (1) (2024)
Sara A Scott, Ellen M Marin, Kathryn T Maples, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Sagar Lonial, Ajay K Nooka
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience. Blood cancer journal 13 (1) (2023)
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo, Alberto C Moreno, Jeffrey M Switchenko, Suneethamma Cheedarla, Deon Bryant Doxie, Roman Radzievski, Madison Leigh Ellis, Kelly E Manning, Bushra Wali, Rajesh M Valanparambil, Kathryn T Maples, Essence Baymon, Jonathan L Kaufman, Craig C Hofmeister, Nisha S Joseph, Sagar Lonial, John D Roback, Alessandro Sette, Rajesh M Valanparambil, Mehul S Suthar, Andrew S Neish, Madhav V Dhodapkar, Kavita M Dhodapkar
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections. Blood cancer discovery 4 (2) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Kathryn T Maples, Kevin H Hall, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Ajay K Nooka, Sagar Lonial
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience. Blood cancer journal 13 (1) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Kathryn T Maples, Kevin H Hall, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Ajay K Nooka, Sagar Lonial
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience. Blood cancer journal 13 (1) (2023)
Kathryn T Maples, Kevin H Hall, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Ajay K Nooka, Sagar Lonial
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience. Blood cancer journal 13 (1) (2023)
Juan José Lahuerta, Irene Manrique, Julie A Rytlewski, Timothy Campbell, Christian C Kazanecki, Nathan Martin, Larry D Anderson, Jesus G Berdeja, Sagar Lonial, Noopur S Raje, Yi Lin, Phillipe Moreau, Jesús San F Miguel, Nikhil C Munshi, Shari Kaiser
Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel. Blood cancer discovery (2023)
Paola Neri, Benjamin G Barwick, David Jung, Jonathan C Patton, Ranjan Maity, Ines Tagoug, Caleb K Stein, Rémi Tilmont, Noemie Leblay, Sungwoo Ahn, Holly Lee, Seth J Welsh, Daniel L Riggs, Nicholas Stong, Erin Flynt, Anjan Thakurta, Jonathan J Keats, Sagar Lonial, Peter Leif Bergsagel, Lawrence H Boise, Nizar J Bahlis
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. Blood cancer discovery (2023)
Seth J Welsh, Benjamin G Barwick, Erin W Meermeier, Daniel L Riggs, Chang-Xin Shi, Yuan Xiao Zhu, Meaghen E Sharik, Megan T Du, Leslie D Abrego Rocha, Victoria M Garbitt, Caleb K Stein, Joachim L Petit, Nathalie Meurice, Yuliza Tafoya Alvarado, Rodrigo Fonseca, Kennedi T Todd, Sochilt Brown, Zachary J Hammond, Nicklus H Cuc, Courtney Wittenberg, Camille Herzog, Anna V Roschke, Yulia N Demchenko, Wei-Dong D Chen, Peng Li, Wei Liao, Warren J Leonard, Sagar Lonial, Nizar J Bahlis, Paola Neri, Lawrence H Boise, Marta Chesi, Peter Leif Bergsagel
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma. Blood cancer discovery (2023)
Sara A Scott, Ellen M Marin, Kathryn T Maples, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Sagar Lonial, Ajay K Nooka
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience. Blood cancer journal 13 (1) (2023)
Sara A Scott, Ellen M Marin, Kathryn T Maples, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Sagar Lonial, Ajay K Nooka
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience. Blood cancer journal 13 (1) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Ajay K Nooka, Adam D Cohen, Hans C Lee, Ashraf Z Badros, Attaya Suvannasankha, Natalie Callander, Al-Ola Abdallah, Suzanne Trudel, Ajai Chari, Edward N Libby, Maria Chaudhry, Malin Hultcrantz, K Martin Kortüm, Rakesh Popat, Douglas Sborov, Shawn Hakim, Eric Lewis, Boris Gorsh, Bharat Bhushan, Astrid McKeown, Ira Gupta, Joanna Opalinska, Paul G Richardson, Sagar Lonial
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial. Cancer (2023)
Sara A Scott, Ellen M Marin, Kathryn T Maples, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Sagar Lonial, Ajay K Nooka
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience. Blood cancer journal 13 (1) (2023)
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo, Alberto C Moreno, Jeffrey M Switchenko, Suneethamma Cheedarla, Deon Bryant Doxie, Roman Radzievski, Madison Leigh Ellis, Kelly E Manning, Bushra Wali, Rajesh M Valanparambil, Kathryn T Maples, Essence Baymon, Jonathan L Kaufman, Craig C Hofmeister, Nisha S Joseph, Sagar Lonial, John D Roback, Alessandro Sette, Rajesh M Valanparambil, Mehul S Suthar, Andrew S Neish, Madhav V Dhodapkar, Kavita M Dhodapkar
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections. Blood cancer discovery 4 (2) (2023)
Kathryn T Maples, Kevin H Hall, Nisha S Joseph, Craig C Hofmeister, Vilas A Gupta, Madhav V Dhodapkar, Jonathan L Kaufman, Ajay K Nooka, Sagar Lonial
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience. Blood cancer journal 13 (1) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Noopur S Raje, Kenneth C Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P Hammond, Alexander M Lesokhin, Sagar Lonial, Heinz Ludwig, Phillipe Moreau, Krina Patel, Karthik Ramasamy, Maria-Victoria Mateos-Manteca
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. Blood cancer journal 13 (1) (2023)
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo, Alberto C Moreno, Jeffrey M Switchenko, Suneethamma Cheedarla, Deon Bryant Doxie, Roman Radzievski, Madison Leigh Ellis, Kelly E Manning, Bushra Wali, Rajesh M Valanparambil, Kathryn T Maples, Essence Baymon, Jonathan L Kaufman, Craig C Hofmeister, Nisha S Joseph, Sagar Lonial, John D Roback, Alessandro Sette, Rajesh M Valanparambil, Mehul S Suthar, Andrew S Neish, Madhav V Dhodapkar, Kavita M Dhodapkar
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections. Blood cancer discovery 4 (2) (2023)
Vilas A Gupta, Shannon M Matulis, Benjamin G Barwick, R Devin Bog, Conrad W Shebelut, Mala Shanmugam, Paola Neri, Nizar J Bahlis, Madhav V Dhodapkar, Leonard T Heffner, Craig C Hofmeister, Nisha S Joseph, Sagar Lonial, Jonathan L Kaufman, David L Jaye, Ajay K Nooka, Lawrence H Boise
Venetoclax ex vivo functional profiling predicts improved progression-free survival. Blood cancer journal 12 (8) (2022)
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo, Alberto C Moreno, Jeffrey M Switchenko, Suneethamma Cheedarla, Deon Bryant Doxie, Roman Radzievski, Madison Leigh Ellis, Kelly E Manning, Bushra Wali, Rajesh M Valanparambil, Kathryn T Maples, Essence Baymon, Jonathan L Kaufman, Craig C Hofmeister, Nisha S Joseph, Sagar Lonial, John D Roback, Alessandro Sette, Rajesh M Valanparambil, Mehul S Suthar, Andrew S Neish, Madhav V Dhodapkar, Kavita M Dhodapkar
Impaired SARS-CoV-2 variant neutralization and CD8+ T cell responses following 3 doses of mRNA vaccines in myeloma: correlation with breakthrough infections. Blood cancer discovery (2022)
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo, Alberto C Moreno, Jeffrey M Switchenko, Suneethamma Cheedarla, Deon Bryant Doxie, Roman Radzievski, Madison Leigh Ellis, Kelly E Manning, Bushra Wali, Rajesh M Valanparambil, Kathryn T Maples, Essence Baymon, Jonathan L Kaufman, Craig C Hofmeister, Nisha S Joseph, Sagar Lonial, John D Roback, Alessandro Sette, Rajesh M Valanparambil, Mehul S Suthar, Andrew S Neish, Madhav V Dhodapkar, Kavita M Dhodapkar
Impaired SARS-CoV-2 variant neutralization and CD8+ T cell responses following 3 doses of mRNA vaccines in myeloma: correlation with breakthrough infections. Blood cancer discovery (2022)
Sundararajan Vincent Rajkumar, Shaji K Kumar, Sagar Lonial, Maria-Victoria Mateos-Manteca
Smoldering multiple myeloma current treatment algorithms. Blood cancer journal 12 (9) (2022)
Herve Avet-Loiseau, Jesús San F Miguel, Tineke Casneuf, Shinsuke Iida, Sagar Lonial, Saad Z Usmani, Andrew Spencer, Philippe Moreau, Torben Plesner, Katja Weisel, Jon Ukropec, Christopher Chiu, Sonali Trivedi, Himal Amin, Maria Krevvata, Priya Ramaswami, Xiang Qin, Mia Qi, Steven Sun, Ming Qi, Rachel Kobos, Nizar J Bahlis
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Anita D Souza, Sagar Lonial
What The Princess Bride Teaches Us About Outcomes in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Sagar Lonial, Hans C Lee, Ashraf Z Badros, Suzanne Trudel, Ajay K Nooka, Ajai Chari, Al-Ola Abdallah, Natalie Callander, Douglas Sborov, Attaya Suvannasankha, Katja Weisel, Peter M Voorhees, Lynsey Womersley, January Baron, Trisha Piontek, Eric Lewis, Joanna Opalinska, Ira Gupta, Adam D Cohen
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study. Cancer 127 (22) (2021)
Sagar Lonial, Ajay K Nooka, Praneetha Thulasi, Ashraf Z Badros, Bennie H Jeng, Natalie S Callander, Heather A Potter, Douglas Sborov, Brian E Zaugg, Rakesh Popat, Simona Degli Esposti, Julie Byrne, Joanna Opalinska, January Baron, Trisha Piontek, Ira Gupta, Reza Dana, Asim V Farooq, Kathryn Colby, Andrzej J Jakubowiak
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM). Blood cancer journal 11 (5) (2021)
Ajay K Nooka, Nisha S Joseph, Sagar Lonial
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myeloma. Cancer 127 (22) (2021)
Yanyan Gu, Benjamin G Barwick, Mala Shanmugam, Craig C Hofmeister, Jonathan L Kaufman, Ajay K Nooka, Vikas Gupta, Madhav V Dhodapkar, Lawrence H Boise, Sagar Lonial
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma. Blood cancer journal 10 (12) (2020)
Paul G Richardson, Hans C Lee, Al-Ola Abdallah, Adam David Cohen, Prashant Kapoor, Peter M Voorhees, Axel Hoos, Karrie Wang, January Baron, Trisha Piontek, Julie Byrne, Scott Richmond, Roxanne C Jewell, Joanna Opalinska, Ira Gupta, Sagar Lonial
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study. Blood cancer journal 10 (10) (2020)